Back to Results
First PageMeta Content
Neurosteroids / Progestagens / Progesterone / Prostate cancer / Abiraterone / Selective progesterone receptor modulator / Breast cancer / Trastuzumab / Menopause / Endocrine system / Medicine / Antiandrogens


The Life Sciences Report Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases Source: George S. Mack of The Life Sciences Report: ([removed]The following is an excerpt from an interview with Raghuram
Add to Reading List

Document Date: 2014-05-19 17:40:33


Open Document

File Size: 127,09 KB

Share Result on Facebook

Company

GlaxoSmithKline / Genentech/Roche Holding AG / Johnson & Johnson / Bayer / Schering AG / Arno Therapeutics Inc. / Aegis Capital Corp. / Teva Pharmaceutical Industries Ltd. / Pontifax Group / Janssen Biotech Inc. / Agensys Inc. / Astellas Pharma Inc. / OPKO Health Inc. / Medivation Inc. / /

Country

Israel / /

Currency

USD / /

Event

M&A / /

IndustryTerm

large-cap pharmaceutical pedigree / /

MedicalCondition

cancers / breast cancers / cancer / uterine fibroid treatment / castration-resistant prostate cancer / progesterone receptor-positive tumors / glioblastoma multiforme / endometrial cancers / prostate cancer / breast cancer / uterine fibroids / /

Organization

UCLA / /

Person

Arie Belldegrun / George S. Mack / Ram Selvaraju / /

Position

CEO / Head / principal driver / urologist and biotech startup entrepreneur / physician and also chairman / founder / /

Product

Herceptin / Xtandi / Tykerb / /

Technology

antibodies / /

SocialTag